ABSTRACT SUBMISSION

A. Congress Program and Contents

All of the abstracts to be sent to the Congress must be prepared in English. However, presentations can be made in both languages yet simultaneous translation services in Turkish - English and English - Turkish language pairs will be provided during panel discussions. The panelist will choose the language. PowerPoint presentations must be prepared both in Turkish and in English and they must be delivered to the technical team in the presentation control room at least 3 hours earlier the presentation time.

The English abstracts of the research articles which are accepted for either verbal presentation or poster presentation during the Congress will be published in Psychiatry and Clinical Psychopharmacology Additional Issue, which is included in SCI-E (Science Citation Index Expanded) index as one of the periodical of the Psychopharmacology Association. Thus, especially the research abstracts must not be longer than 400 to 500 words, 5 or 6 keywords must be included, and they must be structured as objective, tools, results, and conclusion.

For more information: https://www.abstractagent.com/2019psychopharmacology/

Important Note for the Assistant Scholarship: The authors that will present verbal or poster papers must register as participants. Among the paper presenters, the registrations of those evidencing that they have specialization, master or doctoral student status will be made free of charge by the Psychopharmacology Association. This free registration right covers 1 person that is included in each paper as a presenter.

B. Types of Sessions to be Included in the Program Scope

1. Guest Speaker Sessions

The speakers of these sessions will be selected by the relevant sessions’ moderators and invited by the organizing committee. No other paper abstract will be allowed in the sessions; however, in case of an exceptional suggestion, please contact the organization’s secretariat at operasyon1@burkon.com.

Abstracts must be written in English, consist of 450 to 500 words, and contain 5 to 6 keywords according to the rules of Psychiatry and Clinical Psychopharmacology (PCP) Journal. 3 references can be added by the end of the abstracts.

2. Verbal Session Speeches

Panel discussions suggestions will be made to the Scientific Committee as a group of 4 speakers ad 2 moderators. Total length of panel discussions is 90 minutes and each presentation must be presented for a maximum 20-minute period. The speakers are kindly requested to take cognizance of their presentation durations so as to leave a minimum 10-minute period for discussions at the end of the sessions.

Abstracts must be written in English, consist of 450 to 500 words, and contain 5 to 6 keywords according to the rules of Psychiatry and Clinical Psychopharmacology (PCP) Journal. 3 references can be added by the end of the abstracts.

The presentations must be accompanied by abstracts that exactly describe them.

Panel discussions will be conducted as 3 parallel sessions and English to Turkish or Turkish to English simultaneous translation services will be provided in the main halls.

3. Verbal Papers / Interactive

These presentations will be 60 minutes in total. The speakers are expected to limit their presentation periods with 20 to 25 minutes to allocate time for discussions.

Abstracts must be written in English, consist of 450 to 500 words, and contain 5 to 6 keywords according to the rules of Psychiatry and Clinical Psychopharmacology Journal. 3 references can be added by the end of the abstracts.

4. Verbal Papers

The length of each verbal presentation is limited with 10 minutes and they are organized as 90-minute sessions made up of 8 presentations. Each speaker should spare 8 minutes for addressing with maximum 8 slides in English and 2 minutes for discussions.

5. Poster Papers

• Posters must be written in English.
• Small fonts (maximum 12) must be used for the sources that can be added no more than 5.
• Other poster parts must be written with a sufficient font size that allows reading at a distance of 1.5 meters.
• Poster size must be 90 cm high x 70 cm wide.
• Research posters must be written in 4 sections under the headings of objective, method, results, and conclusion.
• Case posters must be written in 4 sections under the headings of introduction, case, discussion, and conclusion.
• The research posters, for which award applications have been filed and accepted, will be exhibited in the relevant area during the Congress. Other posters will be divided into 3 separate groups and the paper authors will post their posters at 8:30 in the morning and remove them at 21:00 on the day and in the area notified to them.

Important Note for the Assistant Scholarship: The authors that will present verbal or poster papers must register as participants. Among the paper presenters, the registrations of those evidencing that they have specialization, master or doctoral student status will be made free of charge by the Psychopharmacology Association. This free registration right covers 1 person that is included in each paper as a presenter.

C. Papers to Apply for the Research Encouragement Awards

Paper Subject Headings

The paper abstract must be uploaded under the most appropriate heading for the content. Author names, academic titles, institution addresses, and the responsible author’s email address and cell phone number must be provided.

Content

Research Presentations must consist of maximum 1500 words except for the heading, author’s name, institution details and addresses, and references. The articles must be structured (Objective - Tool and Method - Results - Discussion). 5 to 6 keywords must be added:
– Objective: The research's tested hypothesis or analyzed/assessed objective must be explained.
– Method: The period, place, location, setup, and population used in the research and the methods used in information gathering and in the statistical analysis must be explained.
– Results: The results and conclusion of the research must be explicitly explained. The special results obtained must be explicitly noted.
– Conclusions: The conclusions obtained, importance of the conclusions, and possible inference must be explained.

Important Note:Case presentations can be sent only as posters and the paper texts are not necessarily to be structured.

• Paper abstracts must be written in the areas of psychopharmacology, neuroscience, adult psychiatry, and child and adolescent psychiatry and they must not have been published before.
• Abbreviations that may denominate specific medication names and trade names must never be used.
• Common abbreviations can be used, while the abbreviations that are not frequently used must be accompanied in the first sentence with their full expansions followed by their abbreviations between parentheses. All psycho-pharmaceuticals used must be clearly specified.
• The research field of presentations must be specified by being uploaded under one of the subject headings.

Writing Order

• All papers must be uploaded in English
• The paper text’s responsibility resides solely with the author; thus, the authors must carefully review the texts for writing errors.

Authors

• During the online submission, the institution details regarding the author(s) must be filled in.
• The presenter will be published as being underlined among the authors.

Keywords

• 5 to 6 keywords must be selected from Medical Subject Headings (MeSH) list that is checked by National Library of Medicine (NLM) and used in the indexing of articles for PubMed.

Sources

• Maximum 3 references are allowed. They must be referred to within the publication text by using consecutive numbers between brackets; [1], [2], and [3]. References must be inserted as shown in the following example:
Kose S, Celikel FC, Akin E, Kaya C, Cumurcu B, Etikan I, Cloninger CR. Normative Data and Factorial Structure of the Turkish Version of the Junior Temperament and Character Inventory-Revised (J TCI-R). Psychiatry and Clinical Psychopharmacology 2017;27(1): 6-13.

Assessment of Papers

Criteria to be Used in Assessing the Papers: 
1. Are the research objectives clear and explicit? 
2. Are the methods used appropriate for the research objectives? 
3. Are the results significant and have they been presented clearly? 
4. Are the conclusions supported by the results? 
5. Is the research genuine and does it contribute to the field?
6. Clinical practicability of the subject?
7. The content quality and manner of presentation?
8. Language and formatting quality?
9. Compliance with the rules of 1500 words and 5 to 6 sources and with NLM format?

Publication

The abstracts of the posters and verbal presentations that are accepted by the Congress Scientific Committee and presented in the Congress will be published in the Congress USB and the USB will be delivered to the registered participants free of charge. Further, the USB content will be published in Psychiatry and Clinical Psychopharmacology Congress Supplementary Issue.

Among the Researcher Presentations sent to the Congress, the ones that are written in accordance with the rules explained in Article C will be published in the Clinical Psychopharmacology Congress Additional Issue. The Editor of Psychiatry and Clinical Psychopharmacology reserves the copyrights relating to these articles and, upon uploading their articles to the system, the authors acknowledge that the information given and abstracts sent by the authors do not violate the copyright laws and that there is no conflict of interest.